← Back to Search

Arm 1 Enhanced Mindfulness Intervention (EMI) - Immediate Group for Astrocytoma

N/A
Waitlist Available
Led By Staci M Peron, Ph.D.
Research Sponsored by National Cancer Institute (NCI)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

Study Summary

This trial is testing whether mindfulness is feasible and acceptable for children and young people with high-grade high-risk cancer with poor prognosis and their caregivers.

Eligible Conditions
  • Astrocytoma
  • Brain Metastases
  • Glioblastoma
  • Leukemia
  • Sarcoma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percent of Participants (Parent/Child) With Treatment Specific Retention Among All Randomized Participants, With a Target Retention Rate of 70% Over the 8 Week EMI/Control Period
Percent of Participants Who Completed a Mean of 4 Days/Week At-home Practices or More
Percentage of Eligible Dyads (Parent-child) Who Enroll During a Two-year Period
+1 more
Other outcome measures
Number of Participants With Serious and/or Non-serious Adverse Events Assessed by the Common Terminology Criteria for Adverse Events (CTCAE v4.0)

Trial Design

2Treatment groups
Active Control
Group I: Arm 1 Enhanced Mindfulness Intervention (EMI) - Immediate GroupActive Control1 Intervention
Participate in an in-person session followed by a series of at-home assignments, and two booster sessions.
Group II: Arm 2 Control Group - Psychoeducation GroupActive Control1 Intervention
Participants will briefly meet with a member of the research team who will assess parent and child coping, and provide the child- caregiver dyad educational material about coping with cancer

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)Lead Sponsor
13,665 Previous Clinical Trials
40,925,844 Total Patients Enrolled
140 Trials studying Astrocytoma
13,592 Patients Enrolled for Astrocytoma
Staci M Peron, Ph.D.Principal InvestigatorNational Cancer Institute (NCI)
7 Previous Clinical Trials
491 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers
Staci Peron, Ph.D. 2019. "Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03538587.
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top